What's Happening?
Ecolab Life Sciences has launched a new bioprocessing applications laboratory (BPAL) in Dongtan, Korea, marking its first bioprocessing facility in Asia. This expansion aims to provide local support to biopharmaceutical manufacturers across Asia, enhancing
their access to downstream process development. The facility will assist in optimizing chromatography steps, improving yield and productivity, and accelerating regulatory pathways. This initiative is part of Ecolab's strategy to support the rapidly growing biopharmaceutical manufacturing sector in Asia, which includes countries like Korea, China, Japan, India, and Singapore.
Why It's Important?
The establishment of the BPAL in Korea is significant for the biopharmaceutical industry in Asia, as it provides local manufacturers with the technical support needed to meet stringent regulatory and performance standards. By reducing the need to ship materials overseas for development, the lab helps manufacturers shorten development cycles and maintain consistency with global operations. This local presence is crucial for the region's growing pipelines in biosimilars and monoclonal antibody processes, enabling faster scale-up and reducing development risks.
